EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study

Yixing Tian iD, Jinqi Wang, Tianyu Zhu, Xia Li, Haiping Zhang, Xiaoyu Zhao, Xinghua Yang, Yanxia Luo, Lixin Tao iD, Zhiyuan Wu, Xiuhua Guo iD

Nutrients · 2025

DOI: 10.3390/nu17111783 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Nutrients, 2025. Verfasst von Yixing Tian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: Multimorbidity, Cardiovascular Diseases, Renal Insufficiency, Chronic, Aging. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Program of Natural Science Fund of China, Capital's Funds for Health Improvement and Research, Program of Natural Science Fund of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Previous studies have confirmed that biological age (BA) acceleration is associated with single cardio-renal–metabolic diseases (CRMDs), typically including type 2 diabetes mellitus, cardiovascular disease, and chronic kidney disease. However, its association with progression to cardio-renal–metabolic multimorbidity (CRMM, coexistence of ≥2 CRMDs) and subsequent mortality remains unexplored.

Methods

Using the multi-state model, we analyzed 278,927 UK Biobank participants free of CRMDs at baseline to investigate the association between BA acceleration—measured by phenotypic age (PhenoAge) and Klemera–Doubal method age (KDMAge)—and CRMM progression trajectory, from health to the first CRMD and then to CRMM and death. BA acceleration was the residual from regressing BA on chronological age; positive values indicated a biologically older individual.

Results

PhenoAge acceleration showed stronger associations than KDMAge acceleration. Per the 1-SD increase in PhenoAge acceleration; HRs (95% CIs) were observed at 1.18 (1.17–1.19) for baseline to first CRMD; 1.24 (1.22–1.26) for first CRMD to CRMM; 1.25 (1.22–1.27) for baseline to death; 1.13 (1.11–1.15) for first CRMD to death; and 1.09 (1.06–1.12) for CRMM to death. Biologically older individuals by PhenoAge acceleration showed greater reductions in CRMD-free and total life expectancy than those by KDMAge acceleration. Age, socioeconomic status, education, smoking status, alcohol consumption, physical activity, and diet-modified risks for specific transitions.

Conclusions

BA acceleration, particularly PhenoAge acceleration, relates to higher CRMM progression risk and shorter life expectancy. Combining BA acceleration with sociodemographic or lifestyle factors improves risk identification for specific transitions. BA acceleration offers the potential to guide CRMM prevention across its entire progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultimorbidityCardiovascular DiseasesRenal Insufficiency, ChronicAgingDiabetes Mellitus, Type 2Metabolic DiseasesHumansMaleFemaleProspective StudiesMiddle AgedAgedDisease ProgressionAge FactorsUnited KingdomRisk Factors

Stichwörter der Autor:innen

biological agecardiovascular diseaseschronic kidney diseasediabetesmultimorbidity

Autor:innen und Institutionen

  • Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing 100069, China.
  • Department of Mathematics and Statistics, La Trobe University, Melbourne 3086, Australia.
  • Department of Nutrition, Harvard T.H. Chan School of Public Health, 655 Huntington Ave, Boston, MA 02115, USA.
  • National Institute for Data Science in Health and Medicine, Capital Medical University, Beijing 100069, China.
  • School of Medical and Health Sciences, Edith Cowan University, Perth 6027, Australia.
  • Beijing Key Laboratory of Environment and Aging, Capital Medical University, Beijing 100069, China.

ORCID-Profile: Yixing Tian, Lixin Tao, Xiuhua Guo

Förderung

  • The Program of Natural Science Fund of China
  • Capital's Funds for Health Improvement and Research
  • Program of Natural Science Fund of China
  • Capital’s Funds for Health Improvement and Research

Zitieren

APA

Tian, Y., Wang, J., Zhu, T., Li, X., Zhang, H., Zhao, X., Yang, X., Luo, Y., Tao, L., Wu, Z., & Guo, X. (2025). Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study. Nutrients. https://doi.org/10.3390/nu17111783

Vancouver

Tian Y, Wang J, Zhu T, Li X, Zhang H, Zhao X, et al. Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study. Nutrients. 2025. doi:10.3390/nu17111783

BibTeX
@article{Tian2025,
  author = {Tian, Yixing and Wang, Jinqi and Zhu, Tianyu and Li, Xia and Zhang, Haiping and Zhao, Xiaoyu and Yang, Xinghua and Luo, Yanxia and Tao, Lixin and Wu, Zhiyuan and Guo, Xiuhua},
  title = {Biological Age Acceleration Associated with the Progression Trajectory of Cardio-Renal–Metabolic Multimorbidity: A Prospective Cohort Study},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17111783}
}
Kostenlos starten →